Laboratory of Lymphocyte Signaling and Oncoproteome

Re-activation of mitochondrial apoptosis inhibits T cell lymphoma survival and treatment resistance

Spinner, S Crispatzu, G Yi JH Munkhbaatar, E Mayer, P Höckendorf, U Müller, N Li, Z Schader, T Bendz, H Hartmann, S Yabal, M Pechloff, K Heikenwalder, M Kelly, GL Strasser, A Peschel, C Hansmann, ML Ruland, J Keller, U Newrzela, SHerling, MJost, PJ
Leukemia 30, 7July, 2016Pages: 1520-30doi: 10.1038/leu.2016.49ISSN: 1476-5551

Full text


New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

November 21, 2019

New meta-analysis on JAK/STAT genomic alterations in T-PLL published in Cancers.